Cas:942069-69-4 2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane manufacturer & supplier

We serve Chemical Name:2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane CAS:942069-69-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Chemical Name:2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS.NO:942069-69-4
Synonyms:2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular Formula:C13H17BCl2O3
Molecular Weight:302.98900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:27.69000
Exact Mass:302.06500
LogP:3.30120

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Use and application,2-(3,5-dichloro-4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane technical grade,usp/ep/jp grade.


Related News: Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. 7-(benzyloxy)-6-methoxy-1-methyl-3,4-dihydroisoquinoline hydrochloride manufacturers A major advantage of identifying suitable biocatalysts early on is that it provides ample opportunity for optimization. 1-Phenyl-2-phenylhydrazono-1H-pyrrol-3(2H)-one suppliers Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. 4-ethenyl-2-methyl-2-prop-1-ynyloxetane vendor & factory After recently opening one cell therapy plant and breaking ground on another in Massachusetts, Takeda is pivoting westward to beef up production in California.,A major advantage of identifying suitable biocatalysts early on is that it provides ample opportunity for optimization.